What Causes Plaque in the Eye? Four Types and Their Triggers

Four distinct deposits in or around the eye each stem from a completely different underlying trigger. Ocular plaque refers to yellowish or whitish accumulations of lipids, proteins, or cholesterol that settle in different eye structures, including the retina, cornea, retinal arteries, and eyelids. Some deposits come from normal aging, while others point to elevated LDL cholesterol, carotid atherosclerosis, or early age-related macular degeneration. Knowing which type sits behind your diagnosis shapes everything that happens next.

You will find a clear breakdown of the four main plaque types, the mechanisms behind each, the symptoms that tend to surface, and the specialists worth seeing. By the final section, you will be able to match a finding to its likely cause and choose between a routine recheck, a lipid panel, or a same-day vascular workup.

The Term “Eye Plaque” Covers Several Distinct Conditions

Ophthalmologists use “plaque” as a catch-all for any yellowish or whitish deposit that shows up during an eye exam, but the word hides more than it reveals. Lipid accumulation in the cornea behaves nothing like cholesterol emboli lodged in a retinal artery, and protein-rich drusen beneath the retina follow yet another pathway. The American Academy of Ophthalmology classifies these as separate conditions even though patients often hear a single phrase for all of them.

The location tells most of the story. A deposit hugging the edge of the cornea, a speck inside a retinal vessel, a soft patch on the eyelid, and a cluster of yellow specks under the retina all share the word “plaque” yet share almost nothing in cause or consequence. Confusing them is what leads people to shrug off findings that deserve a cardiology referral or panic over a harmless age-related ring that never affects vision.

Why the Difference Matters for Your Health Decisions

Treatments and urgency scale with the underlying mechanism. A corneal arcus found in a 70-year-old with normal blood lipids is mostly cosmetic, while the same finding in a 40-year-old often triggers a cholesterol workup. A single Hollenhorst plaque seen during a routine exam can shift someone from “no heart history” into a vascular imaging protocol overnight.

Sorting the categories up front lets you skip vague worry and head straight to the right specialist. The table below maps the four common plaque types to where they form and what their presence usually signals.

The Four Major Types of Ocular Plaque and Where They Form

Each plaque type earns its name from the tissue where it settles, and the tissue itself hints at the cause. A deposit that builds inside a blood vessel almost always traces back to atherosclerosis somewhere upstream, while a deposit that drifts onto the eyelid skin points to circulating lipids the body is trying to shed.

Drusen Beneath the Retina

Drusen are small yellowish specks made of lipids, proteins, and cellular waste that accumulate between the retinal pigment epithelium and Bruch’s membrane. They mark the defining lesion of age-related macular degeneration (AMD), the leading cause of central vision loss in older adults in the United States. The National Eye Institute estimates that roughly 11 million Americans live with some form of AMD, and drusen appear in nearly all of them.

Calcific drusen harden over time and add to oxidative stress that damages the photoreceptors above them. A few small drusen scattered across the macula are common after age 50 and may stay harmless for decades, while larger or more numerous drusen raise the risk of progression to advanced AMD.

Corneal Arcus Around the Iris

Corneal arcus, also called arcus senilis, appears as a white or grayish ring tracing the outer edge of the cornea, separated from the limbus by a narrow clear zone. Cholesterol deposits diffuse into the corneal stroma from the blood vessels at the corneal margin, then arrange themselves in that characteristic circle. After age 60, the ring is so common it usually counts as a normal aging change.

In adults under 50, the same ring signals a different story. The presence of corneal arcus before middle age correlates with elevated LDL cholesterol and a higher lifetime risk of cardiovascular events, which is why ophthalmologists flag it for younger patients and refer them for lipid testing.

Hollenhorst Plaque Inside a Retinal Artery

A bright yellow cholesterol crystal breaks loose from an atherosclerotic plaque in the carotid artery, travels through the bloodstream, and lodges in a branch of the retinal artery, where it becomes known as a Hollenhorst plaque. It looks like a glinting speck against the orange-red retina during a dilated exam and acts as a forme fruste stroke, a warning that a larger embolic event could follow.

The Mayo Clinic and major stroke-prevention guidelines treat visible retinal emboli as a marker of increased short-term stroke risk. Patients with a Hollenhorst plaque typically move directly into vascular workup, including carotid imaging and aggressive management of blood pressure, lipids, and antiplatelet therapy decisions made by their physician.

Xanthelasma on the Eyelid

Soft, flat, yellowish plaques frequently appear on the upper or lower eyelid, most often near the inner corner, in a condition called xanthelasma. Histologically, they are foamy macrophages, immune cells that have absorbed so much cholesterol they look foamy under a microscope, sitting just beneath the skin. Roughly half of patients with xanthelasma have normal serum cholesterol, which is why researchers now study the condition as an independent lipid-metabolism signal rather than a simple mirror of LDL levels.

Even when blood lipids look fine, xanthelasma clusters with a higher lifetime risk of heart disease and ischemic events in large cohort studies. Dermatology and ophthalmology practices treat the lesions for cosmetic reasons, but the underlying finding still warrants cardiovascular risk assessment.

Underlying Causes and Risk Factors Behind Each Plaque Type

The four plaque types share some risk factors but diverge sharply on others. Mapping each condition to its specific drivers makes prevention and monitoring more useful than generic “eat better and exercise” advice that applies to every plaque at once.

Age, Oxidative Stress, and Genetics for Drusen

Cumulative oxidative stress on the retinal pigment epithelium drives the accelerating buildup of drusen over time. Smoking is the single strongest modifiable risk factor for AMD progression, followed by low dietary intake of leafy greens and omega-3 fatty acids. Variants in complement factor genes, particularly CFH and ARMS2, raise baseline risk in people with a family history of macular degeneration.

UV light exposure adds to retinal oxidative load over decades, which is part of why sunglass use and a diet rich in lutein and zeaxanthin are commonly recommended for people with intermediate drusen. Controlling these inputs does not erase existing deposits, but slows the pace at which new ones form.

Lipid Imbalance and Diabetes for Corneal Arcus and Xanthelasma

Elevated LDL cholesterol, high apolipoprotein B levels, and uncontrolled type 2 diabetes all feed the cholesterol deposits that produce corneal arcus and xanthelasma. Familial hypercholesterolemia, an inherited condition that keeps LDL elevated from birth, can produce both findings before age 30. In people without a genetic cause, the deposits still track with the same lipid markers that drive atherosclerosis elsewhere in the body.

Because xanthelasma can appear even with normal blood lipids, the current thinking is that local lipid handling in the skin, not just circulating cholesterol, contributes to the deposits. Thyroid disease and primary biliary cholangitis also show up more often in patients with xanthelasma, which is why a basic metabolic workup often accompanies the eye finding.

Atherosclerosis as the Source of Hollenhorst Plaques

The carotid artery is the usual source. As atherosclerotic plaque builds in the carotid bifurcation, fragments of cholesterol-rich material can shear off, enter the ophthalmic artery, and wedge into a retinal arteriole. The smaller the retinal branch blocked, the smaller the visual field loss, but the underlying message stays the same: unstable plaque sits somewhere in the carotid system.

Blood pressure, smoking, diabetes, and LDL cholesterol are the modifiable inputs that drive carotid atherosclerosis. Hollenhorst plaques are uncommon in young adults without these risk factors, which is why the finding often triggers a full vascular risk reassessment instead of a routine follow-up.

UV, Wind, and Surface Irritation for Conjunctival Deposits

Plaque-like changes on the conjunctiva, including pinguecula (a yellowish bump on the white of the eye) and pterygium (a wing of tissue that grows onto the cornea), are not true cholesterol plaques but often get mentioned alongside them. They form when chronic UV radiation exposure and wind-driven irritation trigger conjunctival tissue to degenerate and lay down lipid and protein deposits.

People who spend significant time outdoors without UV-blocking sunglasses, especially in sunny or high-glare environments, develop these lesions at higher rates. Protective eyewear and lubrication during prolonged outdoor exposure are the practical defenses.

Symptoms, Warning Signs, and How Each Plaque Type Is Found

Most ocular plaques stay silent until someone looks inside your eye with the right instruments. The few that produce symptoms tend to do so through one of two mechanisms: gradual central vision distortion from drusen-related AMD changes or sudden vascular blockage from a Hollenhorst plaque.

Silent Deposits Found During Routine Exams

Corneal arcus, xanthelasma, and most drusen are detected before symptoms begin. A dilated eye exam lets the ophthalmologist or optometrist see the entire retina, the corneal margin, and the eyelid skin in a single visit. The American Academy of Ophthalmology recommends a comprehensive dilated exam at least every one to two years for adults over 60, which is when most of these deposits first appear.

Optical coherence tomography (OCT) is now standard during these visits. OCT captures cross-sectional images of the macula and can measure drusen volume, a useful way to track whether deposits are stable or growing between appointments.

Vision Changes Worth Treating as Urgent

A Hollenhorst plaque can announce itself with sudden painless vision loss in one eye, a shadowy curtain sweeping across part of the visual field, or transient blackouts that last seconds to minutes (amaurosis fugax). Each of these symptoms suggests that a cholesterol embolus has reached the retinal circulation and that more emboli could follow.

“Sudden blurred vision in one eye, a new dark curtain across any part of your visual field, or brief episodes of vision blackout all warrant same-day evaluation, because they may signal an embolic event rather than a stable finding.

Drusen-related vision changes tend to creep in rather than strike. You may notice straight lines bending when you read, faces looking washed out in the center of your visual field, or a small blind spot that grows slowly over months. These changes still deserve prompt evaluation but rarely require the same-day response an embolic event does.

Which Specialists to See and What to Ask at the Appointment

The right specialist depends on the plaque type, and a single visit often opens the door to the rest. Walking in with a clear list of questions makes that visit more productive.

Building Your Care Team

Optometrists are usually the first to spot plaque findings during an annual dilated exam and can decide whether referral is needed. Ophthalmologists, who are medical doctors specializing in the eye, take over management of drusen and AMD-related changes, including imaging, monitoring schedules, and any in-office procedures that may be warranted.

Cardiologists or vascular medicine specialists should evaluate Hollenhorst plaques and xanthelasma in younger patients, since both findings can signal atherosclerosis or lipid disorders that fall outside an eye doctor’s scope.

For patients under 50 with corneal arcus or xanthelasma, a primary care physician or lipidologist can order the metabolic workup and decide whether statin therapy is appropriate based on overall cardiovascular risk.

Questions Worth Asking at the Visit

Direct, specific questions turn a routine appointment into a productive one. Bring this short list to your next visit:

• ▸Name the subtype: The word “plaque” alone tells you nothing; the specific subtype determines everything that follows.
• ▸Pin down the location: Drusen in the peripheral macula behave differently from drusen directly under the fovea.
• ▸Request a written summary: Ask for a written note so you can track changes over time.
• ▸Match imaging to the finding: OCT for drusen, fundus photography for emboli, and carotid ultrasound for Hollenhorst findings.
• ▸Clarify who orders labs: Ask explicitly, because the eye doctor may assume your primary care physician will handle the referral.
• ▸Identify red flags: Get the specific signs that should send you back in quickly versus ones that can wait for the next scheduled visit.

Prevention, Monitoring, and When to Act Quickly

Most ocular plaque types cannot be reversed once formed, but the systemic conditions that produce them often can be modified. Tailoring prevention to the specific plaque type produces better outcomes than generic advice that ignores which condition you are dealing with.

Prevention Strategies That Match Each Plaque Type

For drusen and AMD risk, smoking cessation is the highest-yield change, followed by a diet rich in dark leafy greens, fish, and nuts. The AREDS2 formulation (vitamins C and E, lutein, zeaxanthin, zinc, and copper) has evidence for slowing progression in people with intermediate AMD, though it is not a general-purpose supplement. Always discuss supplementation with an ophthalmologist before starting, since the formulation is calibrated to specific disease stages and individual circumstances vary.

For corneal arcus and xanthelasma, lipid management through diet, exercise, and physician-supervised lipid-lowering therapy targets the underlying driver. For Hollenhorst plaque, vascular risk reduction matters most: blood pressure control, LDL lowering, smoking cessation, and, when appropriate, antiplatelet decisions made with a vascular specialist. UV protection and lubricating eye drops help with pinguecula and pterygium, the conjunctival changes that often get lumped in with true plaques.

Monitoring Timelines and Red Flags

Monitoring intervals depend on plaque type and severity:

• ▸Drusen: Repeat OCT and dilated exam every 6 to 12 months once intermediate drusen appear; sooner if new symptoms develop.
• ▸Hollenhorst plaque: Immediate vascular workup including carotid imaging and lipid panel, then cardiology-driven follow-up.
• ▸Xanthelasma: Lipid re-evaluation every 1 to 2 years, sooner if blood lipids have not been previously checked.
• ▸Corneal arcus under 50: Prompt cholesterol testing and cardiovascular risk assessment, not just reassurance.

“Same-day evaluation is warranted for sudden blurred vision in one eye, new floaters combined with flashing lights, or any curtain-like shadow sweeping across your visual field, because these patterns can signal an active embolic event rather than a stable plaque.

Reassurance fits age-related arcus in older adults with normal lipids and no concerning symptoms, but never assume any plaque finding is benign until the specific type has been identified. That single piece of information, drusen versus corneal arcus versus xanthelasma versus Hollenhorst plaque, decides whether your next step is a routine recheck, a lipid panel, or a same-day vascular workup.

The Bottom Line

The single most useful thing you can do with a diagnosis of “plaque in the eye” is pin down the exact type. Drusen, corneal arcus, Hollenhorst plaque, and xanthelasma share a name but split into four completely different clinical stories: aging, lipid imbalance, artery disease, and local cholesterol handling. Once the type is clear, the right specialist, the right monitoring schedule, and the right prevention strategy follow naturally.

Ask your eye doctor to name the subtype, location, and recommended follow-up interval in writing so you can track what changes over time and act quickly on the warning signs.

FAQ